Archives
-
N6-Methyl-dATP: A Guide to Assay Interpretation
2026-09-26
N6-Methyl-dATP offers a controlled way to test how adenine N6 methylation affects DNA polymerase behavior, but its value depends on separating substrate incorporation from broader epigenetic claims. This guide connects practical assay design with AML research while clarifying what the LMO2–LDB1 evidence does—and does not—show.
-
From Promoter to Plant Edit: T7 RNA Polymerase
2026-09-25
T7 RNA Polymerase links a defined DNA template to purpose-built RNA reagents. This article examines how that mechanism can support DNA-free CRISPR/Cpf1 research, what plant-editing evidence does—and does not—show, and how translational teams can design a more rigorous RNA workflow.
-
Sodium Orthovanadate in Adipocyte Signaling Workflows
2026-09-25
Use Sodium Orthovanadate to help preserve labile tyrosine-phosphorylation signals during adipocyte lysis and signaling analysis—not as a stand-in for a selective pathway drug. This workflow connects phospho-state preservation to a 3T3-L1 insulin-resistance study while highlighting important metabolic-assay confounders and practical controls.
-
mRNA Synthesis Workflow for Fibroblast Engineering
2026-09-24
A practical guide to using a T7-based mRNA synthesis workflow as the first step toward engineered fibroblasts that locally produce an anti-inflammatory biologic. It separates what the reference study demonstrates from the bench optimization needed to connect mRNA production, LNP delivery, and cell-based assays.
-
How BK Channel Signaling Shapes Cancer Cell Stiffness
2026-09-24
Gajda and colleagues identify potassium efflux and the BK-channel subunit KCNMB1 as regulators of cancer-cell stiffness downstream of MRTFA. Their findings connect cancer-cell mechanics with immune-cell killing and metastatic burden, while highlighting that KCNMB1 loss has different mechanical effects in pericytes and cancer cells.
-
PPH21-Driven Autophagy and Candida Biofilm Resistance
2026-09-23
A 2025 study links the PP2A catalytic-subunit gene PPH21 to autophagy, biofilm formation, and antifungal resistance in Candida albicans. Its genetic, pharmacological, and mouse-model findings support a PPH21–Atg13–Atg1 pathway as a candidate mechanism, while leaving the precise molecular steps and clinical relevance open for further testing.
-
10 mM dNTP Mixture: Assay Design Guide
2026-09-23
Learn how a 10 mM dNTP mixture supports controlled PCR, qPCR, sequencing, and DNA construction. This guide also explains how nucleotide quality affects interpretation of DNA-based LNP trafficking assays without confusing synthesis reagents with nanoparticle formulation variables.
-
Bone Transport and TGF-β1 in Diabetic Foot Ulcer Repair
2026-09-22
A 2026 rat study identifies TGF-β1/TGFBR1 signaling as a molecular link between bone transport, angiogenesis, immune regulation, and diabetic foot ulcer repair. Its multimodal design shows how surgical distraction can alter both local wound biology and systemic inflammatory pathways, while also defining practical limits for interpreting RT-qPCR evidence.
-
Capsazepine: From TRPV1 Blockade to Translation
2026-09-22
A translational framework for using Capsazepine to connect TRPV1 biology with nociception, channel crosstalk, and apoptosis research while maintaining mechanistic and experimental discipline.
-
Remdesivir (GS-5734): Assay Reliability Guide
2026-09-21
This scenario-based guide shows how Remdesivir (GS-5734), SKU B8398, can support better-designed antiviral, viability, proliferation, and cytotoxicity assays. It connects product formulation and published potency benchmarks with practical decisions about controls, dosing, interpretation, and vendor reliability.
-
Tailored CAR Macrophages for Peritoneal Cancer
2026-09-21
The reference study develops a macrophage-targeted mRNA-LNP platform for programming CAR macrophages directly in the peritoneal cavity and systematically compares 36 CAR designs. Its CD3ζ–TLR4 intracellular-domain configuration promoted inflammatory macrophage activity, reshaped the tumor immune microenvironment, increased TCF1+PD-1+ progenitor-exhausted CD8+ T cells, and showed strong rationale for combination with PD-1/L1 therapy.
-
N4-Acetylcytidine: Practical Assay Workflows
2026-09-20
N4-Acetylcytidine provides a defined acetylated cytidine reference for free-nucleoside turnover assays, RNA modification controls, and RNA structure-function analysis. This workflow-focused guide shows how to prepare the reagent, separate nucleoside metabolism from RNA deacetylation, and troubleshoot solubility, matrix, and interpretation issues.
-
Fluorouracil Workflows for Tumor Research
2026-09-19
Build reproducible Fluorouracil dose–response, resistance, and pathway assays with exposure controls designed for solid-tumor models. This workflow connects 5-Fluorouracil cytotoxicity to thymidylate synthase inhibition, DNA-replication stress, and the SMYD2-linked multidrug-resistance biology reported in renal cancer.
-
N4-Acetylcytidine Workflows for RNA Studies
2026-09-18
N4-Acetylcytidine is a defined acetylated cytidine standard for separating free-nucleoside metabolism from ac4C modification on RNA. This guide translates recent ASCH-domain structural findings into practical enzyme assays, analytical controls, RNA structure-function experiments, and troubleshooting workflows.
-
DMH1 Workflow: Precision ALK2 Inhibition
2026-09-18
DMH1 provides a selective way to interrogate ALK2-driven BMP signaling in organoid fate studies and non-small cell lung cancer research. This practical guide connects pathway readouts with migration, proliferation, and differentiation assays while emphasizing solvent control, timing, and model-specific optimization.